Cofactors Competition

A relationship between polyol pathway activity and reduction in endothelium-dependent relaxation in aorta from chronic STZ-diabetic rats has recently been reported (Cameron and Cotter, 1992). In agreement with several previous studies (Oyama et al., 1986 Kamata et al., 1989), endothelial-dependent relaxation was defective in the diabetic rats but the deficit was prevented by prior treatment with an AR inhibitor. The mechanism underlying the defect has been speculated to be due to decreased production of endothelium-derived relaxing factor (EDRF) or nitric oxide, NO (Hattori et al., 1991). It has been speculated that these vascular abnormalities may lead to diminished blood flow in susceptible tissues and contribute to the development of some diabetic complications. NO is synthesized from the amino-acid L-arginine by a calcium-dependent NO synthase, which requires NADPH as a cofactor. Competition for NADPH from the polyol pathway would take place during times of sustained hyperglycaemia and... 

The MPMV CTE is distinct from the HIV-1 RRE in that it must rely on a cellular protein cofactor to function. The next step was to identify this cofactor. Competition and inhibitor experiments revealed that CTE is not dependent on CRM1 nuclear export factor (Bogerd et al., 1998 Otero et al., 1998 Pasquinelli et al., 1997a Saavedra et al., 1997). In addition, microinjection of high levels of CTE in Xenopus oocyte nuclei selectively inhibited mRNA export, while tRNA, U snRNA, and Rev-RRE-dependent RNA export were unaffected (Pasquinelli et al., 1997a Saavedra et al., 1997). Thus, the CTE cofactor was also likely to be a key participant in cellular mRNA export. 

To clarify the role of natural and dietary compounds, an elucidation of the interaction mechanisms of these molecules with the human biological network is required, especially at a molecular level. This includes the rmcover of the biophysical mechanisms by which these compounds bind to receptors or enzymes (i.e., allosteric regulation and inhibition/activation profile) and their kinetics (i.e., reversible/irre-versible, substrate and cofactors competition/non-coiiipetition) that could underlie to specific pharmacological actions. These studies are far to be accomplished because, in many cases, it is experimentally difficult to isolate large amormts of compounds from the natural source and, even when this is possible, it is complicated to dissect their intrinsically polypharmacological roles, rendering this area of research... 

Photoaffinity labeling can be particularly useful when dealing with noncompetitive inhibitors, where the site of binding cannot be inferred from competition with specific substrate or cofactor molecules. 

In the processes that require regeneration of cofactors such as nicotinamide adenine dinucleotide phosphate (NAD(P)H) and adenosine triphosphate (ATP), whole-cell biotransformations are more advantageous than enzymatic systems [12,15]. Whole cells also have a competitive edge over the isolated enzymes in complex conversions involving multiple enzymatic reactions [14]. 

The Li+-induced inhibition of the production of the HSV virus may be related to its actions upon viral DNA polymerase production and activity. Li+ reduces both the synthesis of DNA polymerase in tissue culture and the activity of DNA polymerase in vitro, each by about 50%. It has been proposed that Li+ reduces the biosynthesis of viral polypeptides and nucleic acids, and hence inhibits viral DNA replication by competition with Mg2+, a cofactor of many enzymes [243]. However, the inhibitory effect of Li+ on HSV replication in tissue culture is not affected by Mg2+ levels. A more likely hypothesis is the alteration of the intracellular K+ levels, possibly modifying levels of the high-energy phosphate compounds by replacement of either Na+ or K+ in Na+/K+-ATPase [244]. In tissue culture, HSV replication has been shown to be affected by the... 

It was postulated that the differences in enzyme activity observed primarily result from interactions between enzyme-bound water and solvent, rather than enzyme and solvent. As enzyme-associated water is noncovalently attached, with some molecules more tightly bound than others, enzyme hydration is a dynamic process for which there will be competition between enzyme and solvent. Solvents of greater hydrophihcity will strip more water from the enzyme, decreasing enzyme mobility and ultimately resulting in reversible enzyme deactivation. Each enzyme, having a unique sequence (and in some cases covalently or noncovalently attached cofactors and/or carbohydrates), will also have different affinities for water, so that in the case of PPL the enzyme is sufficiently hydrophilic to retain water in all but the most hydrophilic solvents. 

Both the sulfonamides and trimethoprim interfere with bacterial folate metabolism. For purine synthesis tetrahydrofolate is required. It is also a cofactor for the methylation of various amino acids. The formation of dihydrofolate from para-aminobenzoic acid (PABA) is catalyzed by dihydropteroate synthetase. Dihydrofolate is further reduced to tetrahydrofolate by dihydrofolate reductase. Micro organisms require extracellular PABA to form folic acid. Sulfonamides are analogues of PABA. They can enter into the synthesis of folic acid and take the place of PABA. They then competitively inhibit dihydrofolate synthetase resulting in an accumulation of PABA and deficient tetrahydrofolate formation. On the other hand trimethoprim inhibits dihydrofolate... 

An example of a negative cofactor is the NC2 complex, which can repress the basal transcription level. The NC2 complex consists of two subimits, both displaying homology to the histone proteins. The repressive fimction of NC2 is due to its competition with TFIIB and TFIIA for the promoter binding site, thus blocking formation of the pre-initiation complex. 

Direct inhibition of the formation of a pre-initiation complex complexation of basal transcription factors, such as TFIID or TFIIB, or competition with TFIIB for binding to the promoter. An example for this type of repression is the negative cofactor NC2 (see 1.4.3.2). Transcription repression can also result from phosphorylation of the basal transcription factors. By this token, the repression of transcription observed during mitosis is attributed to the hyperphosphorylation of TBP and TAFs. 

Inhibition studies involving ALR2 have indicated noncompetitive inhibition for virtually all compounds examined to date when the forward (reduction) reaction is monitored. This mode of inhibition is often interpreted as meaning that the inhibitor binds to a site on the enzyme that is independent of the catalytic site. Kinetic and competition studies have both led to this conclusion in the case of ALR2 [24,25]. The crystal structure of the enzyme complexed with both the NADPH cofactor and zopolrestat, however, clearly shows the inhibitor occupying the region directly above the nicotinamide of the NADPH and, therefore, the active site (Figures 5, 6, and 7). 

The rates of the various reactions will vary. This may be due to the availability of cofactors, concentration of enzyme in a particular tissue, competition with other, possibly endogenous, substrates or to intrinsic factors within the enzymes involved. This variation in rates will clearly affect the concentrations of metabolites in tissues, and the half-life of parent compound and metabolites. It may lead to accumulation of intermediate metabolites. 

Enzyme inhibition. The enzymes of biotransformation may be inhibited by a single exposure to chemicals. This occurs by several mechanisms formation of a complex, competition between substrates, destruction of the enzyme, reduced synthesis of the enzyme, allosteric effects, and lack of cofactors. The consequences will depend on the role of metabolism in toxicity in the same way as induction (see above). 

All carbons are derived from either erythrose 4-phosphate (light purple) or phosphoenolpyruvate (pink). Note that the NAD+ required as a cofactor in step (3) is released unchanged it may be transiently reduced to NADH during the reaction, with formation of an oxidized reaction intermediate. Step (6) is competitively inhibited by glyphosate (COO—CH2—NH—CH2—PO ), the active ingredient in the widely used herbicide Roundup. The herbicide is relatively nontoxic to mammals, which lack this biosynthetic pathway. The chemical names quinate, shikimate, and chorismate are derived from the names of plants in which these intermediates have been found to accumulate. 

Inhibition kinetics are included in the second category of assay applications. An earlier discussion outlined the kinetic differentiation between competitive and noncompetitive inhibition. The same experimental conditions that pertain to evaluation of Ku and Vmax hold for A) estimation. A constant level of inhibitor is added to each assay, but the substrate concentration is varied as for Ku determination. In summary, a study of enzyme kinetics is approached by measuring initial reaction velocities under conditions where only one factor (substrate, enzyme, cofactor) is varied and all others are held constant. 

A common practice is to conduct the immobilization procedure in the presence of species that occupy the active site of the enzymes, such as substrates, cofactors, reversible competitive inhibitors, or products, at concentrations preferably above their Michaelis or inhibition constants. Such a precaution is not necessary for the immobilization of CMP-Neu5Ac synthetase. 

---